What is CAGR? What does CAGR table indicate for Unjha Formulations Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Unjha Formulations Ltd Stock Analysis

Q: Is Unjha Formulations Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Unjha Formulations Ltd and arrived at the following conclusion.

Small Cap

Evaluated by 186 users | BSE: 531762 | NSE: |
Pharmaceuticals & Drugs

Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to...

10 Year X-Ray

Standalone basis Standalone basis P Consolidated basis

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Capital Employed	5.36%	6.78%	46.03%	77.9%	36.21%	45.63%	44.7%	24.91%	22.8%	23.29%

Growth Parameters	Growth Parameters Colour Code Guide

Net Sales (Rs. Cr.)	4.4	5.9	5	6.6	8.9	10.4	12.2	11.3	11.4	10.6
Y-o-Y Gr. Rt.	-	33.6%	-15.9%	33.3%	34.5%	16.1%	18%	-7.7%	1.1%	-7.2%
Adjusted EPS (Rs.)	0.22	0.18	0.2	0.28	0.39	0.57	0.66	0.59	0.67	0.68
Y-o-Y Gr. Rt.	-	-18.2%	11.1%	40%	39.3%	46.2%	15.8%	-10.6%	13.6%	1.5%
Book Value per Share (Rs.)	0.93	-0.44	-0.27	-0.04	0.35	0.93	1.59	2.17	3.36	4.05
Adjusted Net Profit	0.1	0.1	0.1	0.1	0.2	0.3	0.3	0.3	0.3	0.3
Net Op. Cash Flow (Rs. Cr.)	0.2	2.1	0.5	0.5	-0.7	0.4	0.4	0.1	-0.1	0.4
Debt to Cash Flow from Ops	12.05	0.13	0	0	-0.57	0	0.12	0	0	0

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Unjha Formulations Ltd. ?

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

Unjha Formulations Ltd. should be analysed on a Standalone basis

CAGR CAGR Colour Code Guide

	9 yrs	5 yrs	3 yrs	1 yr
Net Sales	10.2%	3.5%	-4.7%	-7.2%
Adjusted EPS	13.4%	11.8%	1%	1.5%
Book Value per Share	17.8	63.2	36.6	20.5
Share Price	12.1%	-4.8%	-17.5%	22.4%

Key Financial Parameter	Performance Ratio Colour Code Guide

	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20
Return on Equity (%)	-181.87	566.19	124.75	75.83	57.18	49.54	37.14	24.43	22.04	18.39
Operating Profit Margin (%)	4.37	2.64	3.26	2.54	2.1	3.51	3.09	3.03	2.62	2.34
Net Profit Margin (%)	2.62	1.38	1.82	1.87	1.95	2.48	2.41	2.32	2.62	2.88
Debt to Equity	-9.62	-1.33	0	0	2.53	0	0.06	0	0	0
Working Capital Days	242	156	89	85	74	57	51	65	63	61
Cash Conversion Cycle	39	-20	-112	-108	-65	-40	-29	-36	-26	-13

Management X-Ray

Shareholding Pattern

Entity	Percentage Holding
Promoters	36.92%
Non-Institutions	63.08%

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

FAQs

1. Is Unjha Formulations Ltd a good quality company?

Data is not available for this company.

2. Is current market price of Unjha Formulations Ltd a good price to buy it?

The 5-year analysis of Unjha Formulations Ltd's performance infers:

Unjha Formulations Ltd earnings have grown by 11.8%, whereas share price has depreciated -4.8% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

3. What is Unjha Formulations Ltd share price return in the past 10 years ?

We analysed the performance of Unjha Formulations Ltd share prices over the last 10 years. Here is what we found out:

Unjha Formulations Ltd share price has depreciated 6.3% annually over the past ten years.

About Company

Fibron Powder & Fibron Sugar Free Powder are the branded ayurvedic products of the company, based on psyllium husk. The products met with an

Fibron Powder & Fibron Sugar Free Powder are the branded ayurvedic products of the company, based on psyllium husk. The products met with an overwhelming success in our domestic market. The products mainly caters to somewhat sophisticated market segment who is conscious about their health and at the same time are very particular about various flavour like Orange, Lemon, Lime & Mango taste of the product.

Fibron Powder & Fibron SF powder offer excellent value for the money. Speed U - for could able to promote Fibron Powder & Fibron Powder SF at a most competitive price without sacrificing on quality mainly because their sister concern unit Urvesh Psyllium Industries Ltd. is one of the largest raw material supplier and processor of plyllium in the world. It may be important to note here that even Glaxo India Ltd, Proctor & Gamble, Nicholas Piramal India Ltd are the company's most valued costumers.

The company has entered into an agreement with Nicholas Piramal India for sale of Isabgol Husk based product `Tybogel` and Morepen Laboratories for sale of Dr.Mopren Sat Isabgol.

Urvesh Psyllium Industries Limited is the leading processor and exporter of Psyllium Husk & Powder in India.The company is in this line of business since last 52 years (i.e. from 1949). Initially it processed and supplied Psyllium products in local market but, looking to the worldwide demand, in 1966 it started to export Psyllium Products in the name of Rajendra Brothers. Later on with the increase of demand from overseas buyers there rose a need to expand the business, and thus Urvesh Psyllium Industries was formed in 1985, which later on was converted into a Limited Company in the year 1995.

Product range of the company includes: